Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
-
SDG 9 Industry, Innovation, and Infrastructure
-
SDG 10 Reduced Inequalities
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
-
Investigating metformin and cocaine interactions in the brain at the level of pharmacokinetics, physiology, and proteomics
Evans, M. D. (PI), Spencer, S. (PI), Raleigh, M. D. (CoI), Drake, J. M. (Other Role) & Esguerra, M. (Other Role)
9/1/26 → 6/30/31
Project: Research project
-
Long-acting nanoparticle antidotes for the treatment of synthetic opioid overdose
Raleigh, M. D. (PI) & Baehr, C. A. (CoI)
6/1/26 → 3/31/31
Project: Research project
-
Phase 1a/1b Clinical Trials of Multivalent Opioid Vaccine Components
Birnbaum, A. (PI), Macchietto, M. (PI) & Raleigh, M. D. (PI)
RESEARCH FOUNDATION FOR MENTAL HYGIENE, NATIONAL INSTITUTES OF HEALTH (NIH)
4/1/23 → 3/31/27
Project: Research project
-
Adjuvanted Opioid Vaccine for Treating Fentanyl Use Disorder
Guedes, A. (PI), Raleigh, M. D. (PI), Borgatti, A. M. (CoI) & Pravetoni, M. (Prior Principal Investigator)
UNIVERSITY OF MONTANA, NIH NATIONAL INST OF ALLERGY & INFECT DI
9/30/20 → 9/29/27
Project: Research project
-
Vaccines for fentanyl and its derivatives: A strategy to reduce illicit use and overdose (UG3/UH3)
Birnbaum, A. (PI) & Raleigh, M. D. (PI)
UNIVERSITY OF WASHINGTON, NATIONAL INSTITUTES OF HEALTH (NIH)
8/1/22 → 7/31/25
Project: Research project
-
The effects of buprenorphine on fentanyl-induced respiratory depression in rats
Baehr, C. A., Gebo, A., Vigliaturo, J. & Raleigh, M. D., Dec 2025, In: Journal of Pharmacology and Experimental Therapeutics. 392, 12, 103768.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Scopus citations -
β-Nicotyrine and e-cigarette abuse liability I: Pharmacodynamics and interaction with pharmacokinetics and discriminative stimulus effects of nicotine in rats
Smethells, J. R., Wilde, S., Muelken, P., Vigliaturo, J., Raleigh, M. D., Pravetoni, M., Kellar, K. J., Olson, T., LeSage, M. G. & Harris, A. C., Dec 1 2025, In: Drug and alcohol dependence. 277, 112949.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Scopus citations -
Evaluating the rate of reversal of fentanyl-induced respiratory depression using a novel long-acting naloxone nanoparticle, cNLX-NP
Averick, S. E., Kassick, A. J., Song, D., Zhang, B., Vigliaturo, J., Luengas, D., Silva-Ortiz, P., Pravetoni, M. & Raleigh, M. D., 2024, In: Frontiers in Psychiatry. 15, 1366186.Research output: Contribution to journal › Article › peer-review
Open Access8 Link opens in a new tab Scopus citations -
Monoclonal Antibodies Engineered with Fc Region Mutations to Extend Protection against Fentanyl Toxicity
Khaimraj, A., Baehr, C. A., Hicks, D., Raleigh, M. D. & Pravetoni, M., Sep 1 2024, In: Journal of Immunology. 213, 5, p. 663-668 6 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations -
Multivalent Vaccination Strategies Protect against Exposure to Polydrug Opioid and Stimulant Mixtures in Mice and Rats
Song, D., Crouse, B., Vigliaturo, J., Wu, M. M., Heimisdottir, D., Kassick, A. J., Averick, S. E., Raleigh, M. D. & Pravetoni, M., Feb 9 2024, In: ACS Pharmacology and Translational Science. 7, 2, p. 363-374 12 p.Research output: Contribution to journal › Article › peer-review
8 Link opens in a new tab Scopus citations